Pulmatrix (PULM) Proxy filing summary

Executive summary

• Special meeting postponed from October 16 to October 26, 2026, at 8:30 a.m. ET; meeting remains virtual, and the proposals and August 28 record date are unchanged.

• Postponement allows stockholders more time to review the supplement and annual report and submit votes; voting instructions are due by 11:59 p.m. ET on October 25.

• Previously submitted proxies remain valid unless revoked; a later-dated proxy replaces an earlier one.

Voting matters and shareholder proposals

• Nine proposals remain on the ballot; the board recommends FOR Proposals 1–6, 8 and 9, and a 3-year frequency for Proposal 7.

• Proposal 1 covers merger-related share issuance exceeding 20% of pre-merger outstanding shares and the change of control; Proposal 8 seeks approval of the Eos Incentive Plan.

• Proposal 9 authorizes adjournment if needed to solicit additional votes for Proposals 1–8.

Board of directors and corporate governance

• Director nominees Michael J. Higgins and Anand Varadan are standing for election to terms ending at the 2029 annual meeting; if the merger closes, their election applies only until closing, when the board is reconstituted.